Formulations of T-Type Calcium Channel Modulators and Methods of Use Thereof
Praxis Precision Medicines, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/US2020/041530, filed Jul 10, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,427,540 | Formulations of T-Type Calcium Channel Modulators and Methods of Use Thereof In force · Medium confidence UsedRemaining | Praxis Precision Medicines, Inc. | In force | Medium confidence | ||
| US 11,649,207 | Formulations of T-Type Calcium Channel Modulators and Methods of Use Thereof In force · Medium confidence | Praxis Precision Medicines, Inc. | In force | Medium confidence | ||
| US 12,077,502 | Formulations of T-Type Calcium Channel Modulators and Methods of Use Thereof In force · Low confidence | Praxis Precision Medicines, Inc. | In force | Low confidence | ||
| US 12,528,772 | Formulations of T-Type Calcium Channel Modulators and Methods of Use Thereof In force · High confidence | Praxis Precision Medicines, Inc. | In force | High confidence | ||
| Application 18/746,428 | Formulations of T-Type Calcium Channel Modulators and Methods of Use Thereof Pending Not granted | Praxis Precision Medicines, Inc. | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Praxis Precision Medicines, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.